Skip to main content
Clinical and Vaccine Immunology : CVI logoLink to Clinical and Vaccine Immunology : CVI
. 2006 Mar;13(3):329–332. doi: 10.1128/CVI.13.3.329-332.2006

Recognizing Primary Immune Deficiency in Clinical Practice

Hale Yarmohammadi 1,*, Lissette Estrella 1, John Doucette 2, Charlotte Cunningham-Rundles 1
PMCID: PMC1391953  PMID: 16522773

Abstract

Primary immunodeficiency results in recurrent infections, organ dysfunction, and autoimmunity. We studied 237 patients referred for suspicion of immunodeficiency, using a scoring system based on clinical information. The 113 patients with immunodeficiency had higher scores and more episodes of chronic illnesses and were more likely to have neutropenia, lymphopenia, or splenomegaly.


Primary immunodeficiency (PI) diseases may be recognized due to sinopulmonary or gastrointestinal tract infections, organ abscesses, autoimmunity, or systemic signs, such as fever or failure to thrive (3, 6, 11, 14, 32). However, because of the diversity of immune defects, range of ages, and different clinical manifestations, distinguishing patients with PI in practice can be challenging. While delays in diagnosis are common (12, 19, 32), studies have shown an 8 to 24% incidence of immunodeficiency in selected patient populations (7, 8, 12, 19, 24, 25, 29).

We previously used a computerized method to identify potentially immunodeficient patients repeatedly hospitalized due to illnesses characteristic of PI (15); 30% of a cohort of these subjects had immune defects (15). In the present study, we evaluated a group of physician-referred patients because of conditions suggestive of immunodeficiency. Our goal was to determine if patients shown to have immune defects had differences from patients who did not.

MATERIALS AND METHODS

Study participants and testing.

Adult or pediatric patients who were referred by a physician between 1 January 2001 and 1 July 2003 were asked to participate in the study. Laboratory studies included analyses of immune globulins and antibody responses to vaccines (tetanus, diphtheria, pneumococcus [12 serotypes], Haemophilus influenzae) and isohemagglutinin titers (13, 23). Diagnosis of immunoglobulin G1 (IgG1) or IgG2 subclass deficiency was defined as IgG1 or IgG2 levels 2 standard deviations less than the age-related means for individuals with antibody deficiencies (2). Lymphocyte surface markers, lymphocyte proliferation, neutrophil reduction of dihydrorhodamine, and complement testing were done by standard assays (13, 16, 23, 30). A diagnosis of immune deficiency was made by the use of standard criteria (10).

Historical information.

The clinical histories for a 5-year period were reviewed. Diagnoses were confirmed by cultures, radiographic procedures, or the review of the records from the referring physicians. As described previously, illnesses suggestive of PI (4, 9, 12, 18, 20, 22, 27, 28, 31, 32) (Table 1) were recorded on a case report form. These illnesses or conditions were arbitrarily assigned a score of “1”, “2,” or “3” to indicate relative severity (15). Chronic conditions were counted only once in a year's time. An immunodeficiency-related (IDR) score was the sum of the scores acquired over the previous 5 years. To account for the various ages of the patients, the number of years of observation was expressed as the number of “person years” of observation.

TABLE 1.

Scores of diagnoses and conditions assessed from the clinical record

Diagnosis or condition Score Diagnosis or condition Score
Pneumonia, organism 3 Malabsorption 2
    unknown Giardiasis 2
Bacterial pneumonia 3 Autoimmune hemolytic 2
Septicemia 3     anemia
Empyema 3 Chronic sinusitisa 1
Bronchiectasis 3 Chronic bronchitisa 1
Osteomyelitis 3 Chronic otitis media 1
Other abscess 3 Chronic diarrheaa 1
Aseptic meningitis 3 Acute bronchitis 1
Splenic abscess 3 Acute sinusitis 1
Chronic mastoiditisa 3 Fever of unknown origin 1
Bacterial meningitis 3 Cutaneous candidiasisa 1
Liver abscess 3 Suppurative otitis media 1
Lung abscess 3 Failure to thrive 1
Lymphopenia 2 Thrush 1
Cellulitis 2 Lymphadenitis 1
Neutropenia 2 Gastroenteritis 1
Splenomegaly 2 Mycosis 1
Lymphadenopathy 2 Acute otitis media 1
Immune thrombocytopenia 2 Abnormal weight loss 1
a

Diagnoses counted as chronic conditions counted only once in a 12-month period.

Statistical analysis.

Chi-square analysis was used to compare the IDR scores for both groups. The numbers of conditions in both groups were compared by using age-adjusted time (“person years”) and the Mann-Whitney U test (SPSS statistical software; SPSS, Inc., Cary, NC). A multivariate analysis was performed by evaluating each diagnosis and its association with PI. A P value of less than 0.05 was considered significant.

RESULTS

From 1 January 2001 to 1 July 2003, 237 patients were referred by internists, pediatricians, or allergists for suspected immunodeficiency. Of the patients referred, 52% were females and 72% were Caucasians. The median age was 24.5 years (range, 1 to 85 years); immunodeficiency was diagnosed in 113 patients (48%) (Table 2).

TABLE 2.

Characteristics of patient groupsa

Characteristic Percent
Immune deficient (n = 113) Patients without known immunodeficiency (n = 124)
Gender
    Male 49.0 47.0
    Female 51.0 53.0
Age (yr)
    0-1 6.0 8.1
    1-5 20.3 27.4
    6-10 3.5 7.3
    11-20 10.6 11.1
    21-30 9.7 6.5
    31-40 9.7 13.7
    41-50 17.4 7.3
    51-60 12.3 8.1
    61-70 9.7 6.5
    >70 0.8 4.0
Race or ethnicity
    Hispanic 13.4 16.9
    Caucasian 76.9 67.7
    African American 3.5 8.1
    Asian 3.5 4.9
    Other 0.9 2.4
a

The median age of the immune-deficient group was 31.5 years, and that of patients without a known immunodeficiency was 15 years.

For patients with immunodeficiency, the most common diagnosis was common variable immunodeficiency (32%), followed by IgG subclass deficiency and IgA deficiency (Table 3). For the 124 patients not found to have an immune defect, the reasons for referral included chronic bronchitis, chronic sinusitis, pneumonia, and acute or chronic otitis media. These patients had asthma (n = 11), allergic rhinitis and/or atopic dermatitis (n = 8), or food allergies (n = 2). Twenty-three percent of the patients had autoimmune or inflammatory diseases, including rheumatoid arthritis (n = 4), unspecified autoimmunity (n = 3), systemic lupus erythematosus (n = 1), or fibromyalgia rheumatica (1). Other subjects had Crohn's disease (n = 3); diabetes mellitus (n = 2); chronic warts (n = 2); or (one each) quadraplegia, swallowing disorder, cleft palate, osteogenesis imperfecta, Gaucher's disease, sarcoidosis, Epstein-Barr virus-related lymphohistiocytosis, obsessive compulsive disorder, alopecia areata, Hirshprung's disease, familial Mediterranean fever, growth hormone deficiency, or ulcerative colitis.

TABLE 3.

Diagnoses for patients with identified immune deficiencya

Diagnosis No. of patients Median age (yr) Age or age range (yr) Score range
Common variable immune deficiency 38 40 2-65 0-25
IgG1 or IgG2 subclass deficiency 14 43 3-64 2-21
Selective IgA deficiency 12 46 10-64 1-29
Lymphopeniab 9 59 3-85 2-30
Mucocutaneous candidiasis 6 15.5 1-39 4-15
Neutropenia (autoimmune, cyclic and idiopathic)c 6 2 1-3 5-12
Transient hypogamma globulinemia of infancy 3 2 1-2 1-7
Chronic granulomatous disease 3 2 1-20 5-9
T and B combined defectd 2 6.5 5-8 4-30
IgA deficiency and IgG2 subclass deficiency 2 10 9-11 2-13
IgA and IgG deficiency 2 27.4 20-35 4-6
IgA deficiency and lymphopenia 2 44 28-60 3-8
DiGeorge anomaly 2 7.5 1-14 0-6
Antibody deficiency, normal immune globulins 2 53.5 44-63 5-7
Hyper IgE syndrome 2 4.5 4-5 4-9
Complement deficiencye 2 22 2-42 12-19
Lymphopenia and IgG2 deficiency 1 30 11
Leukocyte adhesion deficiency type 2 1 1 13
Common variable immune deficiency and neutropenia 1 41 10
Combined immune defect with multiple intestinal atresias (17) 1 1 3
Hyper IgM syndrome 1 4 14
Familial lymphohistiocytosis 1 2 6
a

A total of 113 patients were evaluated.

b

Chronic lymphopenia (total lymphocyte count, less than 600/ mm3). Four patients had idiopathic CD4 lymphocytopenia (26) one patient had Down syndrome, and one patient had lymphopenia in association with autoimmune liver disease. No clear cause was identified for three patients.

c

Six patients with neutropenia. Four patients had autoimmune neutropenia, one had cyclic neutropenia, and one is chronically neutropenic after sepsis.

d

Includes a 5-year-old girl and an 8-year-old boy with unexplained combined lymphoproliferative immune deficiency with autoimmunity, not autoimmune lymphoproliferative syndrome.

e

Includes two patients with severe complement deficiency: a 42-year-old woman with autoimmune liver disease and with C3, C4, and factor B and absent total hemolytic complement and a 2-year-old with a prolonged absence of total hemolytic complement with bacterial sepsis and fungemia.

Immune deficiency-related scores and specific medical conditions.

Patients with immunodeficiency had a median score of 8 (interquartile range, 5 to 13), which was significantly higher (P = 0.004) than the median score for those who did not (median score, 6; interquartile range, 3 to 10). By the use of age-adjusted comparisons, patients with immune deficiency had a median score of 10 (interquartile range, 5 to 17.5), which was higher (P = 0.025) than the median score of those without immune deficiency (median score, 8; interquartile range, 4 to 14). However, an IDR score of 8 or greater had a positive predictive value of 59%. By consideration of the patients' medical conditions, patients with immunodeficiency had significantly more person years of chronic sinusitis, chronic bronchitis, chronic otitis media, and chronic diarrhea than patients without immune defects (P = 0.001, 0.001, 0.001, and 0.001, respectively) (Table 4). Lymphopenia, thrombocytopenia or neutropenia, and splenomegaly were also more characteristic of immunodeficiency (P = 0.011, 0.027, and 0.011, respectively). In multivariate analyses, splenomegaly was associated with immunodeficiency (odds ratio [OR] = 7.9), followed by neutropenia (OR = 5.0), chronic diarrhea (OR = 2.5), and chronic sinusitis (OR = 1.8). Acute otitis media and suppurative otitis were found more frequently in patients without immune defects (P = 0.001 and 0.012, respectively).

TABLE 4.

Comparison of diagnoses and conditions for patient groups

Condition Actual no. of conditions in 5 yr for:
Comparison of person yr (P value)b
Patients with immunodeficiency (n = 113) Patients without immunodeficiency (n = 124)
Chronic sinusitisa 162 59 0.001b
Chronic bronchitisa 93 60 0.002b
Chronic otitis mediaa 81 39 0.001b
Pneumonia 60 89 0.068
Chronic diarrheaa 43 16 0.001b
Acute sinusitis 22 36 0.157
Bacterial pneumonia 23 40 0.087
Lymphopenia 17 5 0.011b
Cutaneous candidiasis 12 6 0.179
Neutropenia 12 3 0.027
Splenomegaly 10 1 0.011b
Immune thrombocytopenia 6 1 0.027b
Suppurative otitis media 6 21 0.012b
Acute otitis media 6 43 0.001b
Abnormal weight loss 5 13 0.137
a

Counted only once in a year's time.

b

Significant differences between both groups of patients by categorization of each condition as person years.

DISCUSSION

Primary immunodeficiency diseases are relatively rare disorders, but patients with such diseases may appear in general clinical practice. While severe immune defects are more easily recognized, milder defects may not be diagnosed until illness or hospitalization occurs. However, determination of which patients should be evaluated is not always clear, since conditions that occur in immunodeficient subjects are common in subjects with healthy immune systems.

We previously used a scoring system based on the codes of the International Classification of Diseases, version 9 (34), for hospitalized subjects (15) to identify potentially immunodeficient patients. A minimum score of 6 allowed us to identify subjects with immune defects, although most subjects had higher scores (15). In the present study we used a similar method, which we applied to the medical records of patients referred by other physicians. While patients with immunodeficiency had a higher median score than those without immunodeficiency, due to the clinical overlap of conditions, the sensitivity of the IDR scores alone to the identification of PI was low. However, chronic sinusitis, bronchitis, otitis media, and chronic diarrhea were found more often in the immunodeficient group. Note that while pneumonia is characteristic of immunodeficiency (1, 5, 12, 21, 32, 33), this condition was common in both groups.

In a prior report, only 10% of 238 children with recurrent pneumonia had immune defects (24), suggesting that while pneumonia is a useful hallmark of PI, it is a nonspecific indicator.

A scoring system previously proved useful for the identification of immunodeficient subjects in a cohort of patients who had had multiple hospitalizations; a similar scoring system coupled with specific clinical indicators may provide a useful guide to the identification of such patients in the outpatient setting.

Acknowledgments

This work was supported by grants AI-101093, AI-467320, and AI-48693 from the National Institutes of Health and NIAID contract 03-22.

REFERENCES

  • 1.Ballow, M. 2002. Primary immunodeficiency disorders: antibody deficiency. J. Allergy Clin. Immunol. 109:581-591. [DOI] [PubMed] [Google Scholar]
  • 2.Buckley, R. H. 2002. Immunoglobulin G subclass deficiency: fact or fancy? Curr. Allergy Asthma Rep. 2:356-360. [DOI] [PubMed] [Google Scholar]
  • 3.Buckley, R. H. 2004. The multiple causes of human SCID. J. Clin. Investig. 114:1409-1411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Buckley, R. H., R. I. Schiff, S. E. Schiff, M. L. Markert, L. W. Williams, T. O. Harville, J. L. Roberts, and J. M. Puck. 1997. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J. Pediatr. 130:378-387. [DOI] [PubMed] [Google Scholar]
  • 5.Busse, P. J., S. Razvi, and C. Cunningham-Rundles. 2002. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J. Allergy Clin. Immunol. 109:1001-1004. [DOI] [PubMed] [Google Scholar]
  • 6.Chapel, H., R. Geha, and F. Rosen. 2003. Primary immunodeficiency diseases: an update. Clin. Exp. Immunol. 132:9-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Chee, L., S. M. Graham, D. G. Carothers, and Z. K. Ballas. 2001. Immune dysfunction in refractory sinusitis in a tertiary care setting. Laryngoscope 111:233-235. [DOI] [PubMed] [Google Scholar]
  • 8.Coleman, L. T., S. S. Kramer, R. I. Markowitz, and R. M. Kravitz. 1995. Bronchiectasis in children. J. Thorac. Imaging 10:268-279. [PubMed] [Google Scholar]
  • 9.Conley, M. E., and V. Howard. 2002. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia. J. Pediatr. 141:566-571. [DOI] [PubMed] [Google Scholar]
  • 10.Conley, M. E., L. D. Notarangelo, and A. Etzioni. 1999. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin. Immunol. 93:190-197. [DOI] [PubMed] [Google Scholar]
  • 11.Cooper, M. D., L. L. Lanier, M. E. Conley, and J. M. Puck. 2003. Immunodeficiency disorders. Hematology (Am. Soc. Hematol. Educ. Program):314-330. [DOI] [PubMed]
  • 12.Cunningham-Rundles, C. 2001. Common variable immunodeficiency. Curr. Allergy Asthma Rep. 1:421-429. [DOI] [PubMed] [Google Scholar]
  • 13.Cunningham-Rundles, C. 2003. Immune deficiency: office evaluation and treatment. Allergy Asthma Proc. 24:409-415. [PubMed] [Google Scholar]
  • 14.Cunningham-Rundles, C., and P. P. Ponda. 2005. Molecular defects in T- and B-cell primary immunodeficiency diseases. Nat. Rev. Immunol. 5:880-892. [DOI] [PubMed] [Google Scholar]
  • 15.Cunningham-Rundles, C., P. Sidi, L. Estrella, and J. Doucette. 2004. Identifying undiagnosed primary immunodeficiency diseases in minority subjects by using computer sorting of diagnosis codes. J. Allergy Clin. Immunol. 113:747-755. [DOI] [PubMed] [Google Scholar]
  • 16.Folds, J. D., and J. L. Schmitz. 2003. 24. Clinical and laboratory assessment of immunity. J. Allergy Clin. Immunol. 111:S702-S711. [DOI] [PubMed] [Google Scholar]
  • 17.Gilroy, R. K., P. F. Coccia, J. E. Talmadge, L. I. Hatcher, S. J. Pirruccello, B. W. Shaw, Jr., R. J. Rubocki, D. L. Sudan, A. N. Langnas, and S. P. Horslen. 2004. Donor immune reconstitution after liver-small bowel transplantation for multiple intestinal atresia with immunodeficiency. Blood 103:1171-1174. [DOI] [PubMed] [Google Scholar]
  • 18.Grimbacher, B., S. M. Holland, J. I. Gallin, F. Greenberg, S. C. Hill, H. L. Malech, J. A. Miller, A. C. O'Connell, and J. M. Puck. 1999. Hyper-IgE syndrome with recurrent infections—an autosomal dominant multisystem disorder. N. Engl. J. Med. 340:692-702. [DOI] [PubMed] [Google Scholar]
  • 19.Hermaszewski, R. A., and A. D. Webster. 1993. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q. J. Med. 86:31-42. [PubMed] [Google Scholar]
  • 20.Hong, R. 1998. The DiGeorge anomaly (CATCH 22, DiGeorge/velocardiofacial syndrome). Semin. Hematol. 35:282-290. [PubMed] [Google Scholar]
  • 21.Kainulainen, L., J. Nikoskelainen, and O. Ruuskanen. 2001. Diagnostic findings in 95 Finnish patients with common variable immunodeficiency. J. Clin. Immunol. 21:145-149. [DOI] [PubMed] [Google Scholar]
  • 22.McGeady, S. J. 1987. Transient hypogammaglobulinemia of infancy: need to reconsider name and definition. J. Pediatr. 110:47-50. [DOI] [PubMed] [Google Scholar]
  • 23.Noroski, L. M., and W. T. Shearer. 1998. Screening for primary immunodeficiencies in the clinical immunology laboratory. Clin. Immunol. Immunopathol. 86:237-245. [DOI] [PubMed] [Google Scholar]
  • 24.Owayed, A. F., D. M. Campbell, and E. E. Wang. 2000. Underlying causes of recurrent pneumonia in children. Arch. Pediatr. Adolesc. Med. 154:190-194. [DOI] [PubMed] [Google Scholar]
  • 25.Pasteur, M. C., S. M. Helliwell, S. J. Houghton, S. C. Webb, J. E. Foweraker, R. A. Coulden, C. D. Flower, D. Bilton, and M. T. Keogan. 2000. An investigation into causative factors in patients with bronchiectasis. Am. J. Respir. Crit. Care Med. 162:1277-1284. [DOI] [PubMed] [Google Scholar]
  • 26.Spira, T. J., B. M. Jones, J. K. Nicholson, R. B. Lal, T. Rowe, A. C. Mawle, C. B. Lauter, J. A. Shulman, and R. A. Monson. 1993. Idiopathic CD4+ T-lymphocytopenia—an analysis of five patients with unexplained opportunistic infections. N. Engl. J. Med. 328:386-392. [DOI] [PubMed] [Google Scholar]
  • 27.Stiehm, E. R. 1996. Immunologic disorders in infants & children, 4th ed. The W. B. Saunders Co., Philadelphia, Pa.
  • 28.Stiehm, E. R., T. W. Chin, A. Haas, and A. G. Peerless. 1986. Infectious complications of the primary immunodeficiencies. Clin. Immunol. Immunopathol. 40:69-86. [DOI] [PubMed] [Google Scholar]
  • 29.Umetsu, D. T., D. M. Ambrosino, I. Quinti, G. R. Siber, and R. S. Geha. 1985. Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. N. Engl. J. Med. 313:1247-1251. [DOI] [PubMed] [Google Scholar]
  • 30.Vowells, S. J., S. Sekhsaria, H. L. Malech, M. Shalit, and T. A. Fleisher. 1995. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J. Immunol. Methods 178:89-97. [DOI] [PubMed] [Google Scholar]
  • 31.Whaley, K., and W. Schwaeble. 1997. Complement and complement deficiencies. Semin. Liver Dis. 17:297-310. [DOI] [PubMed] [Google Scholar]
  • 32.Winkelstein, J. A., M. C. Marino, R. B. Johnston, Jr., J. Boyle, J. Curnutte, J. I. Gallin, H. L. Malech, S. M. Holland, H. Ochs, P. Quie, R. H. Buckley, C. B. Foster, S. J. Chanock, and H. Dickler. 2000. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79:155-169. [DOI] [PubMed] [Google Scholar]
  • 33.Winkelstein, J. A., M. C. Marino, H. Ochs, R. Fuleihan, P. R. Scholl, R. Geha, E. R. Stiehm, and M. E. Conley. 2003. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 82:373-384. [DOI] [PubMed] [Google Scholar]
  • 34.World Health Organization. 1998. International classification of diseases, 9th revision, clinical modification, 5th edition. World Health Organization, Geneva, Switzerland.

Articles from Clinical and Vaccine Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES